{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-002227","form_type":"8-K","ticker":"TGNT","cik":"0000846377","company_name":"Totaligent, Inc.","filed_at":"2026-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.815734+00:00","generated_at":"2026-05-15T06:16:00.785568+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Totaligent acquires Aetherium Medical ($10M rev); Klarich President, board member","bullets":["Totaligent forms subsidiary Aetherium Medical LLC; Klarich contributes trade secrets, know-how, and business network.","Ivan Klarich appointed President immediately, will join 3-member Board after closing.","Initial 10% fully-diluted equity (Series D Preferred) issued at closing; additional milestone-based equity.","Underlying Aetherium platform generated ~$10M annual revenue with >15 years consistent profitability.","No cash consideration; equity-only. Separate GloMed JV is not a condition of this agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-002227","json":"https://secwatch.observer/filing/0001477932-26-002227.json","markdown":"https://secwatch.observer/filing/0001477932-26-002227.md","text":"https://secwatch.observer/filing/0001477932-26-002227.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/846377/000147793226002227/0001477932-26-002227-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/846377/000147793226002227/totaligent_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:16:00.785568+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3f8c9ef8cffb18f871d31e60d2764cf65ff7fb66","claim":"Totaligent, Inc. entered into Definitive Agreement with Ivan Klarich (effective 2026-04-10).","evidence_excerpt":"On April 10, 2026, Totaligent, Inc. (the “Company”) entered into a Definitive Agreement (the “Definitive Agreement”) with Ivan Klarich (“Klarich”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793226002227/0001477932-26-002227-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Ivan Klarich"},{"label":"Effective","value":"2026-04-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}